The GHRP-2 test shows comparable sensitivity and specificity to insulin tolerance testing with a superior safety profile Body composition : Phase 2 studies examining effects on body composition, showing trends toward increased lean mass and decreased fat mass with repeated dosing Synergy with GHRH : Key studies demonstrating that combined GHRP-2 + GHRH administration produces GH release 2-3 times greater than either agent alone, establishing the mechanistic basis for combination protocols Aging studies : Research showing that GH responses to GHRP-2 are preserved in elderly subjects to a greater degree than responses to GHRH alone, suggesting maintained GHS-R1a sensitivity with aging Cardiac effects : Preclinical evidence of cardioprotective properties through GHS-R1a activation, independent of GH release The primary limitation is that GHRP-2 has not progressed beyond Phase 2 development for any therapeutic indication
Whether senescent cells also activate mechanisms protecting against other types of cell death is unclear
Together, they mimic the bodys natural pulsatile GH release , offering a safer, more natural alternative to synthetic growth hormone injections
Research Use Only CJC-1295/Ipamorelin Blend (CJC-1295 (without DAC), Ipamorelin) has not been evaluated by the FDA for safety or efficacy in humans
Wir weisen ausdrcklich darauf hin, dass unsere Produkte nicht zur Einnahme, Anwendung am oder im menschlichen Krper bestimmt sind
